Boehringer Ingelheim Pharma GmbH & Co. KG · 66-66 · GERMANY

For Boehringer Ingelheim Pharma GmbH & Co. KG, import alert is 66-66; country is GERMANY; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product code is 61 K - - 02 Anisotropine Methylbromide (Anti-Cholinergic) | 61 K - - 31 Methscopolamine Bromide (Anti-Cholinergic); date published is 09/30/2009; address is Boehringer Ingelheim KG. , Binger Str. 173 , Ingelheim am Rhein, Rhineland-Palatinate GERMANY, verified against its source on 2026-09-30.

What the source says

Boehringer Ingelheim Pharma GmbH & Co. KG Date Published : 09/30/2009 Boehringer Ingelheim KG. , Binger Str. 173 , Ingelheim am Rhein, Rhineland-Palatinate GERMANY 61 K - - 02 Anisotropine Methylbromide (Anti-Cholinergic) Date Published: 09/30/2009 Notes: 11/2/2000 61 K - - 31 Methscopolamine Bromide (Anti-Cholinergic) Date Published: 09/30/2009 Notes: 11/2/2000

— accessdata.fda.gov, retrieved 2026-09-15

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

— all from accessdata.fda.gov, retrieved 2026-09-15

The same source also states

Boehringer Ingelheim Pharma GmbH & Co. KG Date Published : 09/30/2009 Boehringer Ingelheim KG. , Binger Str. 173 , Ingelheim am Rhein, Rhineland-Palatinate GERMANY 62 I - - 99 Anti-Neoplastic N.E.C. Date Published: 09/30/2009 Notes: 11/2/2000

— accessdata.fda.gov, retrieved 2026-09-15

Source

• accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified against source: 2026-09-30. Due for re-check by 2026-11-29. This page as Markdown · OKF bundle · full dataset as JSON.